- Open Access
Legionella pneumophila infection induces programmed cell death, caspase activation, and release of high-mobility group box 1 protein in A549 alveolar epithelial cells: inhibition by methyl prednisolone
© Furugen et al. 2008
- Received: 21 January 2008
- Accepted: 01 May 2008
- Published: 01 May 2008
Legionella pneumophila pneumonia often exacerbates acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). Apoptosis of alveolar epithelial cells is considered to play an important role in the pathogenesis of ALI and ARDS. In this study, we investigated the precise mechanism by which A549 alveolar epithelial cells induced by L. pneumophila undergo apoptosis. We also studied the effect of methyl prednisolone on apoptosis in these cells.
Nuclear deoxyribonucleic acid (DNA) fragmentation and caspase activation in L. pneumophila-infected A549 alveolar epithelial cells were assessed using the terminal deoxyribonucleotidyl transferase-mediated triphosphate (dUTP)-biotin nick end labeling method (TUNEL method) and colorimetric caspase activity assays. The virulent L. pneumophila strain AA100jm and the avirulent dotO mutant were used and compared in this study. In addition, we investigated whether methyl prednisolone has any influence on nuclear DNA fragmentation and caspase activation in A549 alveolar epithelial cells infected with L. pneumophila.
The virulent strain of L. pneumophila grew within A549 alveolar epithelial cells and induced subsequent cell death in a dose-dependent manner. The avirulent strain dotO mutant showed no such effect. The virulent strains of L. pneumophila induced DNA fragmentation (shown by TUNEL staining) and activation of caspases 3, 8, 9, and 1 in A549 cells, while the avirulent strain did not. High-mobility group box 1 (HMGB1) protein was released from A549 cells infected with virulent Legionella. Methyl prednisolone (53.4 μM) did not influence the intracellular growth of L. pneumophila within alveolar epithelial cells, but affected DNA fragmentation and caspase activation of infected A549 cells.
Infection of A549 alveolar epithelial cells with L. pneumophila caused programmed cell death, activation of various caspases, and release of HMGB1. The dot/icm system, a major virulence factor of L. pneumophila, is involved in the effects we measured in alveolar epithelial cells. Methyl prednisolone may modulate the interaction of Legionella and these cells.
- A549 Cell
- Acute Lung Injury
- Acute Respiratory Distress Syndrome
- Alveolar Epithelial Cell
- Intracellular Growth
The Legionnaires' disease bacterium, Legionella pneumophila, is one of the most common etiologic agents of bacterial pneumonia. This Gram-negative bacterium can multiply within mononuclear cells in vivo and in vitro , and evade phagosome-lysosome fusion within these cells . An important set of virulence factors expressed by L. pneumophila is the dot/icm system, a type IV secretion system that allows the organism to escape phagosome-lysosome fusion and to grow within the phagolysosome [3, 4]. The ability of L. pneumophila to cause pneumonia is dependent on its capacity to invade and replicate within alveolar macrophages and monocytes . In addition, intracellular replication within alveolar epithelial cells may contribute to the pathogenesis of Legionnaires' disease [5, 6].
Legionella pneumonia is a potentially serious and life-threatening pneumonia [7, 8]. It can exacerbate and develop lethal complications, including acute lung injury (ALI) and acute respiratory distress syndrome (ARDS), a severe form of ALI [9, 10]. ARDS is characterized by flooded alveolar air spaces and increased microvascular and epithelial permeability due to neutrophil inflammation, damage to the alveolar capillary endothelium, and disruption of the alveolar epithelium [11, 12]. Apoptotic epithelial cells are found in the damaged alveolar epithelium of patients with ARDS , implicating such a mechanism in the pathogenesis of ALI and ARDS, including immune recovery and tissue repair after injury . Apoptosis was also induced in L. pneumophila-infected alveolar epithelial cells and, consequently, L. pneumophila is considered to play a key role in cytotoxicity . However, the apoptotic mechanisms operating in alveolar epithelial cells remain largely unexplored.
This study confirmed the intracellular growth and cytotoxicity of L. pneumophila in A549 alveolar epithelial cells. We also investigated the mechanisms of apoptosis of L. pneumophila-infected A549 cells, including nuclear deoxyribonucleic acid (DNA) fragmentation and activation of various caspases. In addition, we examined the release of the high-mobility group box 1 (HMGB1) protein, a late phase mediator of acute lung inflammation , from Legionella-infected alveolar epithelial cells. We also used the avirulent dotO mutant strain of L. pneumophila lacking a functional dot/icm secretion system  to identify bacterial trigger factor(s) for cytotoxicity. Finally, we examined the influence of methyl prednisolone, as an inhibitor of cell injury, on DNA fragmentation, caspase activation, and secretion of HMGB1 from L. pneumophila-infected A549 cells.
The virulent AA100jm strain of L. pneumophila and its avirulent dotO mutant have been described previously . The dotO mutation severely impairs intracellular growth and evasion of the endocytic pathway by the bacterium . Both L. pneumophila strains were grown on buffered charcoal yeast-extract agar medium supplemented with α-ketoglutarate (BCYE-α) at 35°C in a humidified incubator, and subsequently subcultured in buffered yeast extract broth supplemented with α-ketoglutarate (BYE-α).
The human alveolar epithelial cell line A549 was maintained in RPMI 1640 medium (Nipro, Osaka, Japan) containing 10% heat-inactivated fetal bovine serum (Biological Industries, Kibbutz Beit Haemek, Israel), at 37°C in humidified air under 5% CO2.
Cultured A549 cells in 24-well plates containing 1.25 × 105 cells/well were infected with L. pneumophila at a multiplicity of infection (MOI) of 100. The plates were spun down at 1,300 revolutions per minute (rpm) (about 150 × g) for 10 minutes. After incubation for 2 hours, the extracellular fluid and bacteria were removed by washing 3 times with tissue culture medium, and the plates were further incubated for up to 3 days. At various times, the cultured cells were desquamated into the supernatant by gentle scratching with a pipette tip. The supernatant was finally harvested and diluted appropriately with sterile distilled water, and subsequently cultured on BCYE-α agar.
A549 cells were infected with L. pneumophila as described for the colony assay, except for MOIs and incubation times. At various times after incubation, the culture supernatants were harvested. Lactate dehydrogenase (LDH) levels were measured in the supernatants as a marker of cytotoxicity using the LDH-cytotoxic Test Wako (Wako Pure Chemical Industries, Osaka, Japan), according to the instructions provided by the manufacturer. The level of specific cytotoxicity was calculated by the following formula:% of specific LDH release = ([experimental LDH release - the mean of negative control release]/[the mean of positive control release - the mean of negative control release]) × 100.
LDH release from cells treated with 0.05% saponin was used as a positive control, while the negative control was LDH release from nontreated cells.
Quantitation of high mobility group box 1 (HMGB1) protein
A549 cells were infected with L. pneumophila as described for the colony assay. Two days after infection, the culture supernatants were harvested. HMGB1 levels in the supernatants were determined using a sandwich ELISA kit II (Shino-Test Corporation, Kanagawa, Japan)  using pig HMGB1 as a standard, according to the instructions provided by the manufacturer. The detection limit was 1 ng/ml.
The terminal deoxyribonucleotidyl transferase-mediated triphosphate (dUTP)-biotin nick end labeling (TUNEL) method  was used for detection of DNA fragmentation of nuclei. A549 cells grown on glass coverslips in 24-well plates containing 1.25 × 105 cells/well were infected with L. pneumophila at various MOIs. Positive controls were treated with 30 μM mitomycin C. After incubation for 2 days, the glass coverslips were harvested, fixed with 4% paraformaldehyde, and washed with PBS. The cells were permeabilized with 0.5% Tween 20 and treated with MEBSTAIN Apoptosis Kit Direct (Medical and Biological Laboratories Co, Nagoya, Japan). Cells were then treated with RNase and propidium iodide (PI). The nick end labeling was analyzed with a confocal laser scanning microscope (Fluorview, Olympus, Tokyo). TUNEL positive cells were also quantitated using flow cytometry (Flow Cytometer, Coulter Corporation, FL).
Colorimetric assay for caspase activity
Commercially available caspase activity assays (Colorimetric Assay kit; BioVision Research Products, Mountain View, CA) based on colorimetric detection of cleaved para-nitroaniline-labeled substrates specific for caspase 3 (DEVD), 8 (IETD), 9 (LEHD), and 1 (YVAD) were used to analyze caspases activity according to the instructions provided by the manufacturer. Briefly, A549 cells cultured in 8.5-cm dishes containing 7 × 106/dish were stimulated, collected, and lysed on ice. Cleaved samples (4 μg/μL), were incubated at 37°C for 2 hours in the presence of labeled caspase-specific substrate conjugates for caspase 3, 8, 9, and 1. Caspase activity was determined from the sample absorbance at 405 nm measured in a microplate reader (Bio-Rad, Tokyo, Japan).
A549 cells were infected with L. pneumophila or treated with mitomycin C, in a manner similar to caspase activity analysis. After 24 hours, the cells were lysed in a buffer containing 62.5 mM Tris-HCl (pH 6.8), 2% sodium dodecyl sulfate, 10% glycerol, 6% 2-mercaptoethanol, and 0.01% bromophenol blue. Equal amounts of protein (20 μg) were subjected to electrophoresis on sodium dodecyl sulfate-polyacrylamide gels followed by transfer to a polyvinylidene difluoride membrane and probing sequentially with specific antibodies against caspases 8 and 9, and against cleaved poly (ADP-ribose) polymerase (PARP), which is a natural substrate of caspase 3 (Cell Signaling Technology Inc, Danvers, MA). The bands were visualized by enhanced chemiluminescence (Amersham Biosciences, Piscataway, NJ).
Influence of methyl prednisolone on DNA fragmentation, caspase activity, and HMGB1 release
A549 cells were pretreated with or without methyl prednisolone (53.4 μM) for one day, and subsequently stimulated. Cells were then further incubated with or without methyl prednisolone (53.4 μM). DNA fragmentation, caspase activity, and HMGB1 release were assayed in L. pneumophila-infected A549 cells following these treatments. DNA fragmentation was analyzed by flow cytometry, while caspase activity and HMGB1 release were determined as described above.
Statistical significances were determined using the unpaired or paired t-test (for two-category comparison), or ANOVA and SNK test as post hoc test (for comparison of more than three parameters). A significant difference was considered to be P < 0.05.
Intracellular growth and cytotoxicity of L. pneumophila in A549 cells
Nuclear DNA fragmentation of L. pneumophila-infected A549 cells
Caspase activity in L. pneumophila-infected A549 cells
Inhibition of nuclear DNA fragmentation, caspase activation, and HMGB1 release in A549 cells by methyl prednisolone
Cell death is typically discussed as necrosis, apoptosis, or pyroptosis. While necrosis is characterized as accidental cell death due to physical damage, apoptosis is a strictly regulated genetic and biochemical suicide program that is critical during development and tissue homeostasis, and in modulating the pathogenesis of a variety of diseases . A number of pathogens cause host cell death with features of apoptosis [22–24]. Pyroptosis is a recently described type of cell death, in which caspase 1 is activated and inflammatory cytokines are released as cells are dying .
Several previous studies investigated the induction of apoptosis correlated with cytotoxicity in Legionella-infected cells [26, 27, 14]. The present study confirmed that L. pneumophila multiply within A549 alveolar epithelial cells, resulting in cytotoxicity. We investigated the mechanism by which L. pneumophila induces cell injury in A549 cells by the TUNEL method using both confocal laser scanning microscopy and flow cytometric analysis to assess DNA fragmentation at the single cell level. We also assayed caspase activation using colorimetric assays and western blotting. Chromosomal DNA fragmentation that increased dose-dependently with MOI, and the activation of caspase 3, 8, and 9, indicated that some alveolar epithelial cell injury induced by L. pneumophila was attributable to apoptosis. The results suggested that activation of caspase 1 within alveolar epithelial cells might also be involved.
The L. pneumophila mutant strain carrying a defective dot/icm system failed to induce chromosomal DNA fragmentation or caspase activation in A549 cells. However, further studies are needed to ascertain whether the induction of apoptosis in these cells following L. pneumophila infection is dependent on the dot/icm system itself or on the intracellular growth capacity of the bacteria. Gross et al.  suggested that certain intracellular bacteria might inhibit apoptosis to enhance their own survival, thus boosting replication within phagocytes and their continued presence at sites of infection. Another group of bacteria including L. pneumophila promotes the apoptosis of phagocytes, resulting in either control of intracellular growth of the bacteria or evasion of the immune system . Based on the results of the present study, it is difficult to tell whether caspase activation in alveolar epithelial cells works to regulate or augment the infection. Further study is clearly warranted to pursue this proposition.
The caspase family of cysteine proteases is important in regulating apoptosis and the inflammatory response . Caspase 3, main executioner caspase, is specifically required for DNA fragmentation leading to the typical apoptotic pattern of DNA laddering [30–32]. Otherwise, initiator caspases appear to be activated by many apoptosis-inducing stimuli via two major pathways: the death receptor pathway and the mitochondrial/apoptosome pathway . The regulatory protein caspase 8 is directly activated by death receptors, while caspase 9 activation follows mitochondrial stress [34, 35]. Our results here demonstrated for the first time that L. pneumophila induced caspase-dependent cell injury in A549 cells with elevations in caspase 3, 8, and 9 activities. Gao and Abu  demonstrated that the induction of apoptosis by L. pneumophila in macrophages is mediated through activation of caspase 3, while Fischer et al.  similarly implicated caspase 9 and 3 in myeloid cells and T cells.
Some caspases, such as caspase 1, are also important components of signaling pathways associated with the immune response to microbial pathogens. Caspase 1 activation is associated with the maturation of pro-inflammatory cytokines, such as interleukin-1β (IL-1β) and IL-18, but not apoptosis per se . Recent studies on Shigella and Salmonella infections implicated caspase 1 activation in programmed cell death [38, 39] that was different from apoptosis induced by the activation of caspase 3 ; this process was named pyroptosis . Our present study found that caspase 1 was activated by L. pneumophila infection in A549 alveolar epithelial cells, suggesting a correlation with the cytopathic effect on the cells.
This is the first description also of increased HMGB1 protein in the supernatants of alveolar epithelial cells infected with virulent L. pneumophila. HMGB1 is a non-histone nuclear protein with dual function. Inside the cell, HMGB1 binds DNA and regulates transcription, whereas it acts as a cytokine outside the cell [41, 42]. HMGB1 leaks out from necrotic cells and signals to neighboring cells that tissue damage has occurred , and recent reports indicate that HMGB1 might also be released during apoptosis . Therefore, HMGB1 protein is a cytokine released from dying cells, but it is not clear which type(s) of cell death is associated with release of HMGB1 from Legionella-infected alveolar epithelium. In this study, the increased LDH and HMGB1 secreted from AA100jm-infected A549 cells was dependent on the MOI and correlated with an increase in TUNEL-positive cells. This finding suggests a link between HMGB1 release from dying cells and caspase activation.
Glucocorticoids have a dual effect on apoptosis. Cells of hematopoietic origin such as monocytes, macrophages, lymphocytes, and lymphoma cells are very sensitive to glucocorticoid stimulation of apoptosis . In addition, recent studies associated glucocorticoid-induced anti-apoptotic signaling with apoptosis resistance in transformed cells of epithelial origin [20, 45]. We also confirmed that chromosomal DNA fragmentation of AA100jm-infected A549 cells is inhibited by methyl prednisolone, and that this inhibition of cell injury is accompanied by the degradation of caspase 3, 8, and 9. We therefore postulate that the inhibition of caspase-dependent cell injury by methyl prednisolone resulted at least partly from the depressed death receptor and mitochondrial signaling. Moreover, we detected inhibition of caspase 1 in our experiments, which probably related to signaling pathways associated with immune responses to microbial pathogens.
The present in vitro study showed potential pathogenesis of L. pneumophila against human alveolar epithelial cells. L. pneumophila clearly induced the damage of alveolar epithelial cells in dose-dependent and time-dependent manners. The administration of methyl prednisolone at the early stage of L. pneumophila infection may decrease apoptosis in alveolar epithelial cells. Clinical significance of alveolar epithelial cells infection has been pointed out with other Legionella spp., such as Legionella dumoffii , but its role in L. pneumophila infection is not so clear. The present findings warrant further in vivo animal studies and human studies.
Infection of A549 alveolar epithelial cells by L. pneumophila caused cell death, nuclear DNA fragmentation, activation of various caspases, and release of HMGB1. The dot/icm system was identified as a major virulence factor for the effects of L. pneumophila on these cells. This study suggested that the cytopathic effect of L. pneumophila on A549 alveolar epithelial cells is mediated via activation of caspase 3, 8, 9, and 1. Therefore, the mode of cell death could be apoptosis and/or pyroptosis, induced by either death-receptor signaling or mitochondrial stress. In this study, methyl prednisolone had an anti-apoptotic effect on alveolar epithelial cells infected with bacteria. The search for substances that modulate the interaction between alveolar epithelial cells and Legionella may be warranted as a novel therapeutic intervention.
The authors thank Paul H. Edelstein for providing L. pneumophila strain and its mutant. This work was supported by the Takeda Science Foundation, and the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases from Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.
- Fields BS, Benson RF, Besser RE: Legionella and Legionnaires' disease: 25 years of investigation. Clin Microbiol Rev 2002, 15:506–526.View ArticlePubMedPubMed CentralGoogle Scholar
- Horwitz MA: The Legionnaires' disease bacterium ( Legionella pneumophila ) inhibits phagosome-lysosome fusion in human monocytes. J Exp Med 1983, 158:2108–2126.View ArticlePubMedGoogle Scholar
- Roy CR: The Dot/lcm transporter of Legionella pneumophila : a bacterial conductor of vesicle trafficking that orchestrates the establishment of a replicative organelle in eukaryotic hosts. Int J Med Microbiol 2002, 291:463–467.View ArticlePubMedGoogle Scholar
- Segal G, Feldman M, Zusman T: The Icm/Dot type-IV secretion systems of Legionella pneumophila and Coxiella burnetii . FEMS Microbiol Rev 2005, 29:65–81.View ArticlePubMedGoogle Scholar
- Edelstein PH, Edelstein MA, Higa F, Falkow S: Discovery of virulence genes of Legionella pneumophila by using signature tagged mutagenesis in a guinea pig pneumonia model. Proc Natl Acad Sci USA 1999, 96:8190–8195.View ArticlePubMedPubMed CentralGoogle Scholar
- Higa F, Edelstein PH: Potential virulence role of the Legionella pneumophila ptsP ortholog. Infect Immun 2001, 69:4782–4789.View ArticlePubMedPubMed CentralGoogle Scholar
- Marston BJ, Lipman HB, Breiman RF: Surveillance for Legionnaires' disease. Risk factors for morbidity and mortality. Arch Intern Med 1994, 154:2417–2422.View ArticlePubMedGoogle Scholar
- Reingold AL: Role of legionellae in acute infections of the lower respiratory tract. Rev Infect Dis 1988, 10:1018–1028.View ArticlePubMedGoogle Scholar
- Tkatch LS, Kusne S, Irish WD, Krystofiak S, Wing E: Epidemiology of legionella pneumonia and factors associated with legionella-related mortality at a tertiary care center. Clin Infect Dis 1998, 27:1479–1486.View ArticlePubMedGoogle Scholar
- Torres A, Serra-Batlles J, Ferrer A, Jiménez P, Celis R, Cobo E, Rodriguez-Roisin R: Severe community-acquired pneumonia. Epidemiology and prognostic factors. Am Rev Respir Dis 1991, 144:312–318.View ArticlePubMedGoogle Scholar
- Ware LB, Matthay MA: Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 2001, 163:1376–1383.View ArticlePubMedGoogle Scholar
- Li X, Shu R, Filippatos G, Uhal BD: Apoptosis in lung injury and remodeling. J Appl Physiol 2004, 97:1535–1542.View ArticlePubMedGoogle Scholar
- Song Y, Mao B, Qian G: The role of apoptosis and Fas/FasL in lung tissue in patients with acute respiratory distress syndrome. Zhonghua Jie He He Hu Xi Za Zhi 1999, 22:610–612.PubMedGoogle Scholar
- Gao LY, Abu Kwaik Y: Apoptosis in macrophages and alveolar epithelial cells during early stages of infection by Legionella pneumophila and its role in cytopathogenicity. Infect Immun 1999, 67:862–870.PubMedPubMed CentralGoogle Scholar
- Abraham E, Arcaroli J, Carmody A, Wang H, Tracey KJ: HMG-1 as a mediator of acute lung inflammation. J Immunol 2000, 165:2950–2954.View ArticlePubMedGoogle Scholar
- Yamada S, Yakabe K, Ishii J, Imaizumi H, Maruyama I: New high mobility group box 1 assay system. Clin Chim Acta 2006, 372:173–178.View ArticlePubMedGoogle Scholar
- Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992, 119:493–501.View ArticlePubMedGoogle Scholar
- Anderson P: Kinase cascades regulating entry into apoptosis. Microbiol Mol Biol Rev 1997, 61:33–46.PubMedPubMed CentralGoogle Scholar
- Sakahira H, Enari M, Nagata S: Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 1998, 391:96–99.View ArticlePubMedGoogle Scholar
- Herr I, Gassler N, Friess H, Büchler MW: Regulation of differential pro- and anti-apoptotic signaling by glucocorticoids. Apoptosis 2007, 12:271–291.View ArticlePubMedGoogle Scholar
- Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 1995, 267:1456–1462.View ArticlePubMedGoogle Scholar
- Hay S, Kannourakis G: A time to kill: viral manipulation of the cell death program. J Gen Virol 2002, 83:1547–1564.View ArticlePubMedGoogle Scholar
- Moss JE, Aliprantis AO, Zychlinsky A: The regulation of apoptosis by microbial pathogens. Int Rev Cytol 1999, 187:203–259.View ArticlePubMedGoogle Scholar
- Weinrauch Y, Zychlinsky A: The induction of apoptosis by bacterial pathogens. Annu Rev Microbiol 1999, 53:155–187.View ArticlePubMedGoogle Scholar
- Fink SL, Cookson BT: Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect Immun 2005, 73:1907–1916.View ArticlePubMedPubMed CentralGoogle Scholar
- Müller A, Hacker J, Brand BC: Evidence for apoptosis of human macrophage-like HL-60 cells by Legionella pneumophila infection. Infect Immun 1996, 64:4900–4906.PubMedPubMed CentralGoogle Scholar
- Arakaki N, Higa F, Koide M, Tateyama M, Saito A: Induction of apoptosis of human macrophages in vitro by Legionella longbeachae through activation of the caspase pathway. J Med Microbiol 2002, 51:159–168.View ArticlePubMedGoogle Scholar
- Gross A, Terraza A, Ouahrani-Bettache S, Liautard JP, Dornand J: In vitro Brucella suis infection prevents the programmed cell death of human monocytic cells. Infect Immun 2000, 68:342–351.View ArticlePubMedPubMed CentralGoogle Scholar
- Salvesen GS, Dixit VM: Caspases: intracellular signaling by proteolysis. Cell 1997, 91:443–446.View ArticlePubMedGoogle Scholar
- Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S: A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998, 391:43–50.View ArticlePubMedGoogle Scholar
- Liu X, Li P, Widlak P, Zou H, Luo X, Garrard WT, Wang X: The 40-kDa subunit of DNA fragmentation factor induces DNA fragmentation and chromatin condensation during apoptosis. Proc Natl Acad Sci USA 1998, 95:8461–8466.View ArticlePubMedPubMed CentralGoogle Scholar
- Jänicke RU, Sprengart ML, Wati MR, Porter AG: Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 1998, 273:9357–9360.View ArticlePubMedGoogle Scholar
- Creagh EM, Conroy H, Martin SJ: Caspase-activation pathways in apoptosis and immunity. Immunol Rev 2003, 193:10–21.View ArticlePubMedGoogle Scholar
- Desagher S, Martinou JC: Mitochondria as the central control point of apoptosis. Trends Cell Biol 2000, 10:369–377.View ArticlePubMedGoogle Scholar
- Hengartner MO: The biochemistry of apoptosis. Nature 2000, 407:770–776.View ArticlePubMedGoogle Scholar
- Gao LY, Abu Kwaik Y: Activation of caspase 3 during Legionella pneumophila -induced apoptosis. Infect Immun 1999, 67:4886–4894.PubMedPubMed CentralGoogle Scholar
- Fischer SF, Vier J, Müller-Thomas C, Häcker G: Induction of apoptosis by Legionella pneumophila in mammalian cells requires the mitochondrial pathway for caspase activation. Microbes Infect 2006, 8:662–669.View ArticlePubMedGoogle Scholar
- Hersh D, Monack DM, Smith MR, Ghori N, Falkow S, Zychlinsky A: The Salmonella invasin SipB induces macrophage apoptosis by binding to caspase-1. Proc Natl Acad Sci USA 1999, 96:2396–2401.View ArticlePubMedPubMed CentralGoogle Scholar
- Hilbi H, Chen Y, Thirumalai K, Zychlinsky A: The interleukin 1 beta-converting enzyme, caspase 1, is activated during Shigella flexneri -induced apoptosis in human monocyte-derived macrophages. Infect Immun 1997, 65:5165–5170.PubMedPubMed CentralGoogle Scholar
- Hilbi H, Moss JE, Hersh D, Chen Y, Arondel J, Banerjee S, Flavell RA, Yuan J, Sansonetti PJ, Zychlinsky A: Shigella -induced apoptosis is dependent on caspase-1 which binds to IpaB. J Biol Chem 1998, 273:32895–32900.View ArticlePubMedGoogle Scholar
- Dumitriu IE, Baruah P, Manfredi AA, Bianchi ME, Rovere-Querini P: HMGB1: guiding immunity from within. Trends Immunol 2005, 26:381–387.View ArticlePubMedGoogle Scholar
- Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, Tracey KJ: HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285:248–251.View ArticlePubMedGoogle Scholar
- Scaffidi P, Misteli T, Bianchi ME: Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002, 418:191–195.View ArticlePubMedGoogle Scholar
- Bell CW, Jiang W, Reich CF 3rd, Pisetsky DS: The extracellular release of HMGB1 during apoptotic cell death. Am J Physiol Cell Physiol 2006, 291:1318–1325.View ArticleGoogle Scholar
- Herr I, Pfitzenmaier J: Glucocorticoid use in prostate cancer and other solid tumours: implications for effectiveness of cytotoxic treatment and metastases. Lancet Oncol 2006, 7:425–430.View ArticlePubMedGoogle Scholar
- Maruta K, Miyamoto H, Hamada T, Ogawa M, Taniguchi H, Yoshida S: Entry and intracellular growth of Legionella dumoffii in alveolar epithelial cells. Am J Respir Crit Care Med 1998, 157:1967–1974.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.